Aims Salusin-β is a bioactive peptide with peripheral hypotensive, mitogenic and pro-atherosclerotic effects. The present study was designed to determine the roles of salusin-β in paraventricular nucleus (PVN) and its relationship with arginine vasopressin (AVP) in hypertension and sympathetic activation. Conclusion Salusin-β in the PVN increases blood pressure, heart rate and sympathetic outflow via both circulating AVP and AVP in the RVLM in hypertensive rats.
Introduction
Salusins are originally identified from full-length human cDNAs by bioinformatics analyses. They are translated from an alternatively spliced mRNA of human torsion dystonia-related gene (TOR2A), a gene encoding a protein of the torsion dystonia family. Two related peptides salusin-α and salusin-β in human are identified, comprising 28 and 20 amino acids, respectively. Intravenous administration of salusin-α and salusin-β to rats causes rapid, profound hypotension and bradycardia. 1 Salusin-β-like immunoreactivity was detected strongly in the hypothalamus and posterior pituitary, and less abundantly in anterior pituitary and gastrointestinal, immune, and hematopoietic systems, while salusin-α-like immunoreactivity was not detected in any of the rat tissues, indicating that rat salusin-β is immunologically similar to human salusin-β. 2 Paraventricular nucleus (PVN) is an important integrative site in the control of cardiovascular activity and sympathetic outflow via its projections to the intermediolateral column of spinal cord and the rostral ventrolateral medulla (RVLM). 3, 4 The PVN plays a role in regulating several sympatho-excitatory reflexes such as cardiac sympathetic afferent reflex, 5, 6 and adipose afferent reflex. 7, 8 The PVN is known to be very important in sympathetic activation and hypertension in 2K1C hypertensive rats, 9 spontaneously hypertensive rats (SHR), 10 and obesity hypertensive rats. 8 Immunohistochemical analysis of rat tissues showed the presence of salusin-β in the PVN. 11 Salusin-like immunoreactivity was detected in the hypothalamo-neurohypophyseal tract and immunopositive cells were distributed in both parvocellular and magnocellular part of the PVN, suprachiasmatic and supraoptic nucleus, and most of the salusin-like immunoreactivity was detected in vasopressin-but not in oxytocin-containing neurons in these nuclei. 12 Salusin-β stimulates the arginine vasopressin (AVP) release from perifused rat pituitary. 1 However, it is unknown whether salusin-β in the PVN is involved in regulating blood pressure and sympathetic activity. The present study was designed to determine whether salusin-β in PVN contributes to the hypertension and sympathetic activation were randomly subjected to the PVN microinjection of saline, 0.1, 1, 10 or 100 pmol of salusin-β (n=6 for each group). The intervals between injections were at least 40 min for a complete recovery. To exclude the possibility that the effect of salusin-β was caused by diffusion to other brain area, the effects of microinjection of high dose of salusin-β into the anterior hypothalamic area, which is adjacent to the PVN, were determined (n=3).
Experiment 2. To determine the effects of endogenous salusins, anti-salusin-β IgG was used to immunoneutralize salusins in the PVN. Either Sham or 2K1C rats were randomly divided into four groups (n=6 for each group), which were subjected to the PVN microinjection of control IgG (100 ng), anti-salusin-β IgG (100 ng), salusin-β (100 pmol) pretreated with control IgG, or salusin-β pretreated with anti-salusin-β IgG. Salusin-β was administered 5 min after the pretreatment. 
General date
At the end of the 4th week, SBP and MAP in 2K1C rats were significantly higher than those in Sham rats, but no significant difference in body weight or HR was found between Sham and 2K1C rats (Table 1) .
Effects of different doses of salusin-β
Microinjection of salusin-β into the PVN increased RSNA, MAP and HR in a dose-related manner in 2K1C rats, but not in Sham rats. There was a significant linear correlation between the dose of salusin-β and RSNA, MAP or HR change ( Figure 1 ). PVN microinjection of salusin-β (100 pmol) caused immediate increases in the RSNA, MAP and HR in the 2K1C rat, lasting for 20-30 min (see Supplementary material online, Figure S1 ). Microinjection of salusin-β into the anterior hypothalamic area, which is adjacent to the PVN, had no significant effects on RSNA, MAP or HR.
Effects of anti-salusin-β IgG
Microinjection of anti-salusin-β IgG into the PVN decreased the baseline RSNA and MAP, and almost abolished the effects of salusin-β in the PVN on RSNA, MAP and HR in 2K1C rats. No significant effects were found in Sham rats (Figure 2 ).
Salusin-β-like immunoreactivity in PVN
Compared with Sham rats, the number of salusin-β-like immunopositive neurons in the PVN was significantly increased in 2K1C rats (Figure 3 ).
Plasma norepinephrine, AVP and Ang II levels
The plasma norepinephrine, AVP and Ang II levels were higher in 2K1C rats than Sham rats. Microinjection of salusin-β into the PVN further increased the plasma norepinephrine and AVP levels in 2K1C rats, but not in Sham rats.
However, salusin-β had no significant effect on plasma Ang II level in both Sham and 2K1C rats (Figure 4 ).
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Effects of intravenous injection of AAVP or losartan
Intravenous injection of AVP V1-receptor antagonist AAVP decreased the baseline RSNA and MAP, and abolished the effects of salusin-β in the PVN. However, intravenous injection of AAVP had no significant effects on baseline HR in 2K1C rats. Intravenous injection of AT 1 receptor antagonist losartan in 2K1C rats decreased the baseline RSNA, MAP and HR, but failed to attenuate the effects of salusin-β in the PVN ( Figure 5 ).
Effects of PVN microinjection of AAVP
Microinjection of AAVP into the PVN had no significant effects on the baseline RSNA, MAP or HR as well as the effects of salusin-β in the PVN (see Supplementary material online, Figure S2 ).
Effects of RVLM microinjection of AAVP
Microinjection of AAVP into the RVLM had no significant effects on the baseline RSNA, MAP or HR, but abolished the effects of salusin-β on RSNA and HR in the PVN (Figure 6 ).
Discussion
PVN is important in the control of cardiovascular activity and sympathetic outflow. 3, 19, 20 We found that exogenous salusin-β in the PVN increased the RSNA, MAP and HR in a dose-dependent manner in 2K1C rats but not in Sham rats. The number of salusin-β-like immunopositive neurons in the PVN was increased in the PVN in 2K1C rats compared with Sham rats. Furthermore, salusin-β in the PVN increased plasma norepinephrine in 2K1C rats but not in Sham rats. These results suggest that increased salusin-β in the PVN of 2K1C rats may contribute to the sympathetic activation and hypertension. We excluded the possibility that the effects of salusin-β was caused by diffusion into peripheral circulation, because intravenous salusin-β administration to intact anesthetized rats caused hypotension and bradycardia, 1 which was abolished by pretreatment with atropine, a muscarinic receptor antagonist. Saline+Salusin-β. by guest on 
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